View Single Post
Old 12-12-2008, 10:13 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 19,847
Pfizer drug fails to beat tamoxifen at 2.75 years

Pfizer Inc said on Thursday its Aromasin cancer drug was no betterthan tamoxifen at achieving disease-free survival after 2.75 yearsamong postmenopausal women with hormone-sensitive early breastcancer.

More...
News is offline   Reply With Quote